ArticleCureus2024
Utilization of Integrated Ayushman Bharat - Pradhan Mantri Jan Arogya Yojana and Mahatma Jyotirao Phule Jan Arogya Yojana at a Tertiary Care Center in Solapur, India: An Epidemiological Study.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Article
- Article
- Patient-reported challenges in spinal cord injury rehabilitation and integration within the community of a lower middle-income country: opportunities for changing lives.Brain & spine · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Integrated Ayushman Bharat - Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) and Mahatma Jyotirao Phule Jan Arogya Yojana (MJPJAY) is a public-funded health insurance scheme in the state of Maharashtra. The scheme provides end-to-end cashless services for identified diseases through a network of hospitals from both the government sector as well as the private sector, covered under the scheme. AB-PMJAY is a scheme of the government of India. Such publicly funded health insurance schemes help to reduce out-of-pocket expenditure (OOPE). The study was designed with the objective of describing an epidemiological profile of subjects registered under the Integrated MJPJAY and Pradhan Mantri Jan Arogya Yojana at a tertiary care center and identifying the utilization pattern of the scheme.
methodsIt was a record-based, retrospective cross-sectional study. The study population comprised all the cases registered under Integrated AB-PMJAY and MJPJAY from September 1, 2023, to November 30, 2023, at the tertiary care center. The sample size consists of all the cases (n=1978) registered under the scheme at the tertiary care center from September 1, 2023, to November 30, 2023.
resultsThe majority of the subjects (44.39%, n=878) belonged to the age group 40-59 years. In our study, 77.45% (n=1532) of the study subjects got pre-authorization approval. In the case of the pattern of utilization, 56.46% (n=865) of the study subjects utilized medical treatment, and 43.54% (n=667) of the study subjects utilized surgical treatment. In surgical treatment, utilization was higher in polytrauma (15.92%, n=244), followed by general surgery (7.70%, n=118) and ear, nose, and throat (ENT) surgery (5.68%, n=87). In the case of medical treatment, utilization was more in general medicine (14.30%, n=219), followed by nephrology (11.49%, n=176) and neurology (10.64%, n=163).
conclusionThe majority of the subjects availing themselves of registration in the scheme were in the age group 40-59 years. The majority of the subjects utilized medical treatment. In the case of specialty utilization, polytrauma was utilized more, followed by general medicine. The utilization was least in the case of cardiothoracic surgery, followed by dermatology, hematology, and pediatric surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.